Resistance to targeted therapies in breast cancer

We present an in-depth description of resistance to targeted therapies in breast cancer. Targeted therapies discussed here include those used to treat ER+ or Her2+ breast cancers (i.e., Tamoxifen or trastuzumab) or those targeting signaling pathways aberrantly activated in triple negative breast can...

Full description

Saved in:
Bibliographic Details
Other Authors: Prosperi, Jenifer R., (Editor)
Format: eBook
Language: English
Published: Cham, Switzerland : Springer, [2017]
Series: Resistance to targeted anti-cancer therapeutics ; v. 16.
Subjects:
Breast > Cancer > Chemotherapy.
Drug resistance in cancer cells.
elektronické knihy
electronic books
ISBN: 9783319701424
9783319701417
Physical Description: 1 online resource

Cover

Table of contents

Description
Summary: We present an in-depth description of resistance to targeted therapies in breast cancer. Targeted therapies discussed here include those used to treat ER+ or Her2+ breast cancers (i.e., Tamoxifen or trastuzumab) or those targeting signaling pathways aberrantly activated in triple negative breast cancer (i.e., EGFR and Wnt signaling). We have also provided an overview of standard of care as an introduction into the importance of targeted therapy. It is our hope that this volume gives an insight into the landscape of breast cancer treatment, the challenges of targeted therapy, and a glimpse into the future of breast cancer therapy. #xE000.
Bibliography: Includes bibliographical references and index.
ISBN: 9783319701424
9783319701417
ISSN: 2196-551X ;
Access: Plný text je dostupný pouze z IP adres počítačů Univerzity Tomáše Bati ve Zlíně nebo vzdáleným přístupem pro zaměstnance a studenty

Similar Items